Camrelizumab combined with hepatic arterial infusion chemotherapy for the treatment of advanced extrahepatic cholangiocarcinoma before surgery: a single-arm, prospective, open clinical study
Latest Information Update: 15 Jan 2025
Price :
$35 *
At a glance
- Drugs Camrelizumab (Primary) ; Fluorouracil (Primary) ; Oxaliplatin (Primary)
- Indications Cholangiocarcinoma; Gallbladder cancer
- Focus Therapeutic Use
- 15 Jan 2025 New trial record